Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with a type of blood condition called a myeloproliferative neoplasm (MPN) — this includes essential thrombocythemia (ET), polycythemia vera (PV), early-stage myelofibrosis (pre-MF), myelofibrosis (MF), or a related condition not fitting a specific category (MPN NOS). For people with myelofibrosis specifically, only those whose disease is rated as "low" or "intermediate-1" risk using a standard medical scoring system (called DIPSS) are eligible. For all other MPN types, any risk level may be eligible.
- People who are generally well enough to carry out light physical activity with little to no restriction (this is measured using a standard scale called ECOG, with a score of 0 or 1)
- People who have at least one of the following heart or blood vessel risk factors: a body mass index (BMI) over 25, high blood pressure, high cholesterol, diabetes or pre-diabetes, metabolic syndrome, or a past history of heart disease, mini-stroke (TIA), stroke, or problems with blood vessels in the legs or arms. People who do not have any of these risk factors may still be considered, but the trial's lead doctor would need to give special approval first.
Who may not be able to join:
- People with myelofibrosis whose disease is rated "intermediate-2" or "high" risk using the DIPSS scoring system
- People whose general health and ability to do daily activities is significantly limited (an ECOG score above 2)
- People with an injury or health condition that their treating doctor determines would make it unsafe for them to exercise
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gabriela Hobbs, MD, Massachusetts General Hospital
Phone: 617-724-1124
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants that Complete at Least 9 Weeks of the 12 week Program
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.